Cephalon Targets Breckenridge Over Nuvigil Patent
Cephalon Inc. accused Breckenridge Pharmaceutical Inc. on Wednesday of infringing a patent for Nuvigil in its latest Delaware federal court attempt to keep generic-drug makers from selling versions of the narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article